Current Headlines

  1. Researchers Discover Potential Drug For Rare Pediatric Brain Tumor
    11/20/2014

    Researchers at Northwestern Medicine have discovered a new potential drug that shows promise in treating a rare and incurable form of brain tumor in children. 

  2. Merck JV, Hilleman Laboratories Form Collaboration To Fast-Track Oral Cholera Vaccine
    11/20/2014

    Hilleman Laboratories, a vaccine developer and manufacturer based in New Delhi, has signed a Memorandum of Understanding (MoU) with ICD DR, B and Incepta Vaccine to expedite clinical trials and eventual marketing for a new oral cholera vaccine, Business Standard reports.

  3. Researchers Convert Skin Cells To Replace HD-Damaged Brain Cells
    11/20/2014

    A team of researchers at the Washington University School of Medicine in St. Louis reported that they have discovered a way to directly convert human skin cells into a type of brain cell that has been damaged by Huntington’s disease.

  4. Celgene Wins Rights To Moffitt’s Investigational MDS Therapy
    11/20/2014

    The Moffitt Cancer Center announced Monday that it has entered an exclusive licensing agreement with Celgene Corporation, which gives Celgene the exclusive rights to its novel, investigational therapy for Myelodysplastic Syndromes (MDS).

  5. Pfizer Links With Merck KGaA In Immuno-Oncology Mega Deal
    11/19/2014

    Pfizer announced that it has signed up with German firm Merck KGaA to co-develop and market an investigational anti-PD-L1 treatment for several types of cancer.

  6. ADC Market To Reach $3 Billion By 2018, Report Finds
    11/19/2014

    According to a new report from Research and Markets, Antibody drug conjugates (ADCs) are so effective against cancer, that the global market for the agents will reach $3 billion by 2018.

  7. Report: Global Initiatives To Improve Access To Medicine Show Both Strengths And Weaknesses
    11/19/2014

    The Access to Medicine Index (AMI), a report published every two years by an independent initiative based in the Netherlands, ranks top pharmaceutical companies (18 total) based on their efforts to promote better and more global access to medicine.

  8. Presage Biosciences, Takeda Expand Partnership To Identify Oncology Drug Combinations
    11/18/2014

    Presage Biosciences, an oncology company in Seattle, has expanded its partnership with Takeda and its subsidiary Millenium Pharmaceuticals.

  9. Amgen, AstraZeneca Report Phase 3 Brodalumab Meets Endpoints In Psoriasis
    11/18/2014

    Amgen and AstraZeneca report that a Phase 3 trial of brodalumab has met its primary endpoint and all secondary endpoints in the treatment of moderate-to-severe plaque psoriasis.

  10. Sarepta Kickstarts Eteplirsen Study In Muscular Dystrophy
    11/18/2014

    Sarepta Therapeutics announced that it has begun the clinical study of its lead exon-skipping therapeutic candidate eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.